Raposio Edoardo, Libondi Guido, Bertozzi Nicolò, Grignaffini Eugenio, Grieco Michele P
Department of Surgical Sciences, Plastic Surgeon Division, University of Parma, Parma, Italy; Cutaneous, Mini-invasive, Regenerative and Plastic Surgery Unit, Parma University Hospital, Parma, Italy.
J Am Coll Clin Wound Spec. 2016 Jun 29;7(1-3):13-18. doi: 10.1016/j.jccw.2016.06.001. eCollection 2015 Dec.
Recent research suggests that statins might be useful in the process of wound healing, playing a positive immune-modulatory role, improving microvascular function and reducing oxidative stress. The aim of this pilot study was to evaluate the efficacy of topic application of Simvastatin-based cream in the treatment of chronic vascular cutaneous ulcers, comparing this type of treatment to a collagen-based dressing, proven to be effective for ulcer treatment. A total of 20 ulcers were studied in 2 Groups of randomly-chosen patients for a period of one month. In the first Group a 0.5% Simvastatin-based cream was topically administered, while the second Group (control) was treated with an absorbable type I bovine collagen-based medication. Each week, wound healing progress was observed in both Groups, and the ulcers photographed. Wound healing rate was calculated by considering the absolute change in area and by the formula "healing ratio (%) = [(Area - Area)/Area] × 100," both sets of data being related to the days comprised in the study in order to calculate healing rate per day. Statistical analysis was performed by Student test. Study endpoint equaling the time-course changes of ulcer areas. At the end of the study, when considering absolute change in area, the experimental Group appeared to heal better and faster than the control Group although differences between the Groups were not statistically significant. Conversely, rates of wound healing in the experimental and control Groups were 46.88% and 64% respectively, revealing statistically significant differences. ( < 0.05). In conclusion, topic application of a simvastatin-based cream proved to be well- tolerated but not effective in the management of vascular leg ulcers in a 4 week-period.
近期研究表明,他汀类药物可能在伤口愈合过程中发挥作用,具有积极的免疫调节作用,可改善微血管功能并减轻氧化应激。本初步研究的目的是评估基于辛伐他汀的乳膏局部应用治疗慢性血管性皮肤溃疡的疗效,并将这种治疗方法与已被证明对溃疡治疗有效的基于胶原蛋白的敷料进行比较。在两组随机选择的患者中对总共20处溃疡进行了为期一个月的研究。第一组局部应用0.5%基于辛伐他汀的乳膏,而第二组(对照组)用可吸收的I型牛胶原蛋白药物治疗。每周观察两组的伤口愈合进展情况,并对溃疡进行拍照。通过考虑面积的绝对变化并使用公式“愈合率(%)=[(初始面积 - 最终面积)/初始面积]×100”来计算伤口愈合率,两组数据均与研究中的天数相关,以便计算每日愈合率。采用Student检验进行统计分析。研究终点为溃疡面积的时间进程变化。在研究结束时,考虑面积的绝对变化时,尽管两组之间的差异无统计学意义,但实验组似乎比对照组愈合得更好更快。相反,实验组和对照组的伤口愈合率分别为46.88%和64%,显示出统计学上的显著差异(P<0.05)。总之,在为期4周的时间里,基于辛伐他汀的乳膏局部应用耐受性良好,但对下肢血管性溃疡的治疗无效。